AU2017904360A0 - Dosage Regime for Treatment of Kidney Disease - Google Patents

Dosage Regime for Treatment of Kidney Disease

Info

Publication number
AU2017904360A0
AU2017904360A0 AU2017904360A AU2017904360A AU2017904360A0 AU 2017904360 A0 AU2017904360 A0 AU 2017904360A0 AU 2017904360 A AU2017904360 A AU 2017904360A AU 2017904360 A AU2017904360 A AU 2017904360A AU 2017904360 A0 AU2017904360 A0 AU 2017904360A0
Authority
AU
Australia
Prior art keywords
treatment
kidney disease
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2017904360A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimerix Bioscience Pty Ltd
Original Assignee
Dimerix Bioscience Pty Ltd
Filing date
Publication date
Application filed by Dimerix Bioscience Pty Ltd filed Critical Dimerix Bioscience Pty Ltd
Publication of AU2017904360A0 publication Critical patent/AU2017904360A0/en
Withdrawn legal-status Critical Current

Links

AU2017904360A 2017-10-27 Dosage Regime for Treatment of Kidney Disease Withdrawn AU2017904360A0 (en)

Publications (1)

Publication Number Publication Date
AU2017904360A0 true AU2017904360A0 (en) 2017-11-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3212233A4 (en) Combination therapy for treatment of disease
EP3448874A4 (en) Compositions for the treatment of disease
EP3448875A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
EP3261713A4 (en) Blood pump for treatment of bradycardia
EP3790867A4 (en) Kdm1a inhibitors for the treatment of disease
EP3103466A4 (en) Preventive or therapeutic agent for kidney disease
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
EP3304076A4 (en) Methods for determining drug efficacy for treatment of cancer using ratios of cereblon associated proteins
EP3340974A4 (en) Methods for treatment of diseases
EP3373931A4 (en) Heterocyclic compounds for the treatment of disease
EP3730144A4 (en) Agent for treatment of nervous system disease
EP3897602A4 (en) Pharmaceutical combinations for the treatment of cancer
EP3600251A4 (en) Methods of treatment for kidney disease
EP3706867A4 (en) Therapeutic combination for treatment of cerebellar ataxia
EP3630185A4 (en) Treatment of neuroinflammatory disease
EP3471775A4 (en) Hemoglobin-targeted drug delivery for the treatment of cancer
EP3434284A4 (en) Medicine for treating renal disease
EP3310310A4 (en) Apparatus for treatment of menière's disease
AU2017904360A0 (en) Dosage Regime for Treatment of Kidney Disease
AU2017902795A0 (en) Dosage Regime for Treatment of Kidney Disease
AU2017902717A0 (en) Dosage Regime for Treatment of Kidney Disease